Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Aplenc

Showing results (231-240 of 254) with videos related to

Pageof 26
Sort By:
American Journal of Respiratory and Critical Care Medicine|January 25, 2011
ANGPT2 genetic variant is associated with trauma-associated acute lung injury and altered plasma angiopoietin-2 isoform ratioNuala J Meyer, Mingyao Li, Rui Feng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2015
Collaborative Efforts Driving Progress in Pediatric Acute Myeloid LeukemiaC Michel Zwaan, Edward A Kolb, Dirk Reinhardt, et al.
Transplantation and Cellular Therapy|March 15, 2021
Broad-Spectrum Antibiotics and Risk of Graft-versus-Host Disease in Pediatric Patients Undergoing Transplantation for Acute Leukemia: Association of Carbapenem Use with the Risk of Acute Graft-versus-Host DiseaseCaitlin W Elgarten, Yimei Li, Kelly D Getz, et al.
Infection Control and Hospital Epidemiology|April 25, 2022
Risk of bacterial bloodstream infection does not vary by central-line type during neutropenic periods in pediatric acute myeloid leukemiaCaitlin W Elgarten, William R Otto, Luke Shenton, et al.
Cancer Discovery|April 15, 2016
Identification of Predictive Biomarkers for Cytokine Release Syndrome after Chimeric Antigen Receptor T-cell Therapy for Acute Lymphoblastic LeukemiaDavid T Teachey, Simon F Lacey, Pamela A Shaw, et al.
JCO Oncology Practice|September 19, 2025
AML Care at Home: An Evidence-Based Toolkit to Personalize the Care Setting for Recovery From Pediatric AML ChemotherapyAlix E Seif, Sara L McDonough, Emily M Becker-Haimes, et al.
Nature Communications|July 29, 2025
Epigenomic diagnosis and prognosis of Acute Myeloid LeukemiaFrancisco Marchi, Vivek M Shastri, Richard J Marrero, et al.
Journal of the National Cancer Institute|August 20, 2025
Real-world generalizability of clinical trial cytomolecular risk in pediatric acute myeloid leukemia: a report from the REAL-AML cohortDaniel J Zheng, Gary Hettinger, Catherine Aftandilian, et al.
Blood Advances|October 23, 2020
Diagnostic biomarkers to differentiate sepsis from cytokine release syndrome in critically ill childrenCaroline Diorio, Pamela A Shaw, Edward Pequignot, et al.
Journal for Immunotherapy of Cancer|April 17, 2025
CD22-targeted chimeric antigen receptor-modified T cells for children and adults with relapse of B-cell acute lymphoblastic leukemia after CD19-directed immunotherapyRegina M Myers, Amanda M DiNofia, Yimei Li, et al.
Pageof 26

Showing results (231-240 of 254) with videos related to

Sort By:
Pageof 26
American Journal of Respiratory and Critical Care Medicine|January 25, 2011
ANGPT2 genetic variant is associated with trauma-associated acute lung injury and altered plasma angiopoietin-2 isoform ratioNuala J Meyer, Mingyao Li, Rui Feng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2015
Collaborative Efforts Driving Progress in Pediatric Acute Myeloid LeukemiaC Michel Zwaan, Edward A Kolb, Dirk Reinhardt, et al.
Transplantation and Cellular Therapy|March 15, 2021
Broad-Spectrum Antibiotics and Risk of Graft-versus-Host Disease in Pediatric Patients Undergoing Transplantation for Acute Leukemia: Association of Carbapenem Use with the Risk of Acute Graft-versus-Host DiseaseCaitlin W Elgarten, Yimei Li, Kelly D Getz, et al.
Infection Control and Hospital Epidemiology|April 25, 2022
Risk of bacterial bloodstream infection does not vary by central-line type during neutropenic periods in pediatric acute myeloid leukemiaCaitlin W Elgarten, William R Otto, Luke Shenton, et al.
Cancer Discovery|April 15, 2016
Identification of Predictive Biomarkers for Cytokine Release Syndrome after Chimeric Antigen Receptor T-cell Therapy for Acute Lymphoblastic LeukemiaDavid T Teachey, Simon F Lacey, Pamela A Shaw, et al.
JCO Oncology Practice|September 19, 2025
AML Care at Home: An Evidence-Based Toolkit to Personalize the Care Setting for Recovery From Pediatric AML ChemotherapyAlix E Seif, Sara L McDonough, Emily M Becker-Haimes, et al.
Nature Communications|July 29, 2025
Epigenomic diagnosis and prognosis of Acute Myeloid LeukemiaFrancisco Marchi, Vivek M Shastri, Richard J Marrero, et al.
Journal of the National Cancer Institute|August 20, 2025
Real-world generalizability of clinical trial cytomolecular risk in pediatric acute myeloid leukemia: a report from the REAL-AML cohortDaniel J Zheng, Gary Hettinger, Catherine Aftandilian, et al.
Blood Advances|October 23, 2020
Diagnostic biomarkers to differentiate sepsis from cytokine release syndrome in critically ill childrenCaroline Diorio, Pamela A Shaw, Edward Pequignot, et al.
Journal for Immunotherapy of Cancer|April 17, 2025
CD22-targeted chimeric antigen receptor-modified T cells for children and adults with relapse of B-cell acute lymphoblastic leukemia after CD19-directed immunotherapyRegina M Myers, Amanda M DiNofia, Yimei Li, et al.
Pageof 26